Clinical Trials Browser

Recruiting × Prostatic Neoplasms × talazoparib × Clear all

NCT04734730 2026-01-28

Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer

Phase 2 Recruiting

Prostatic Neoplasms

NCT05873192 2025-12-23

Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer

Phase 2 Recruiting

Prostatic Neoplasms

NCT06844383 2025-10-29

TALENT

Phase 2 Recruiting

Adenocarcinoma, Prostatic Neoplasms